Stay informed with the latest litigation news. Explore now

IP Verse

Allergan, Inc. V. Amneal Pharmaceuticals Of New York, Llc - 2:23-cv-06208

Explore the details of the Allergan, Inc. V. Amneal Pharmaceuticals Of New York, Llc case under case number 2:23-cv-06208 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
2:23-cv-06208
Filing Date
Aug 17, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Applications (ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Amneal EU, Limited -
AbbVie Inc. -
Allergan, Inc. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 13, 2025ORDER granting 108 Motion for Extension of Time to Complete Discovery. So Ordered by Magistrate Judge Steven Tiscione on 6/13/2025. (LV)PACER Document
Jun 30, 2025ORDER: The parties shall appear for a telephone status conference on July 2, 2025 at 1:00 PM. The parties are directed to call the AT&T Teleconferencing Center at (571) 353-2301 and to enter Access Code 981400071 when prompted.At the status conference, the parties shall be prepared to discuss trial dates and a schedule for pre-trial submissions.Ordered by Judge Nusrat J. Choudhury on 6/30/2025. (DJL)PACER Document
Jul 3, 2025ORDER: The parties shall appear for a telephone status conference on Tuesday, August 12, 2025 at 10:30am. The parties are directed to call the AT&T Teleconferencing Center at (571) 353-2301 and to enter Access Code 981400071 when prompted.At the status conference, the parties shall be prepared to discuss trial dates and a schedule for any anticipated pre-trial motion practice.Ordered by Judge Nusrat J. Choudhury on 7/3/2025. (DJL)PACER Document
Jul 3, 2025MINUTE ENTRY: Telephone status conference before District Judge Nusrat J. Choudhury held on July 2, 2025. Kevin Patrick Mulry, Christopher N. Sipes, Erica Nicole Anderson, and Douglas Behrens appeared for Plaintiffs Allergan, Inc. and AbbVie Inc. Richard Pettus, Mark Lesko, Jonathan Richard Wise, and Benjamin Witte appeared for Defendants Amneal Pharmaceuticals of New York, LLC and Amneal EU, Limited.The Court discussed with the parties the current discovery schedule and anticipated pre-trial motion practice. The Court so-ordered the parties' joint request for an extension of the discovery schedule (ECF No. 110 ) and set a follow-up telephone conference (see Elec. Order, July 3, 2025). (DJL)PACER Document
Jul 15, 2025ORDER: The Court has reviewed Defendants' motion for reconsideration (ECF No. 114). Plaintiff shall file any response by July 28, 2025. Ordered by Judge Nusrat J. Choudhury on 7/15/2025. (DJL)PACER Document